NorthWest Biotherapeutics Inc (NWBO)

[doingmybest]

I think their plan has been to get value for shareholders by holding on until they get phase 3 done. That would be the time to either sell or partner for the more significant clinical program that is now needed. I think they can limp across the finish line of phase 3 and I am hopeful the second half of this year is much more fun that the first. The key is for the regulatory issue/opportunity to clear up and it is still the real timing wildcard here.